Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000220537 (Single stranded DNA binding protein pseudogene, also known as LOC100132659) is a pseudogene listed in the human genome. Pseudogenes are genomic DNA sequences similar to normal genes but are generally non-functional; they typically arise from gene duplication or retrotransposition events and accumulate mutations that prevent them from expressing functional protein. There are no known biological, therapeutic, or clinical roles for this pseudogene, and it is neither a receptor nor an enzyme. It does not serve as a drug target. The single stranded DNA binding protein (SSB) gene family has members important in DNA replication, repair, and recombination, but as a pseudogene, ENSG00000220537 does not produce functional SSB protein and does not participate in these cellular processes[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Single stranded DNA binding protein pseudogene.